Mauritius Competition Commission Probes Private Healthcare Costs

Mauritius's Competition Commission (CCM) has opened its first formal market inquiry into the private healthcare sector — a landmark move that could reshape how private hospitals, clinics, and health insurers operate on the island. The CCM, the independent statutory body responsible for promoting fair competition in Mauritius, announced the investigation following growing public concern about the rising cost of private medical care and the lack of price transparency in the sector. **What is a market inquiry?** Unlike a standard competition investigation targeting a specific company for wrongdoing, a market inquiry is a broader examination of how an entire sector functions. The CCM will analyse the structure of the private healthcare market — including hospitals, specialist clinics, laboratories, pharmacies, and health insurers — to determine whether competition is working effectively or whether certain practices are driving up costs unfairly for consumers. This is the first time the CCM has used this particular tool since it was granted the power to conduct such inquiries under Mauritian competition law. **Why private healthcare?** Private healthcare in Mauritius has expanded significantly over the past two decades, with major players such as Clinique Darné, C-Care (City Clinic), and Wellkin Hospital serving both locals and medical tourists. However, the sector has attracted criticism over opaque pricing, the bundling of services, and the relationship between insurers and healthcare providers — practices that may limit consumer choice and inflate costs. Many Mauritians rely on private health insurance provided through their employers, yet often find themselves facing significant out-of-pocket expenses. Middle-income families in particular have felt the squeeze as private care costs outpace wage growth. **What the CCM will look at** While the full terms of reference have not yet been published, market inquiries of this nature typically examine: pricing structures and whether they reflect true costs; barriers to entry for new providers; the bargaining power of insurers versus hospitals; and whether patients have access to sufficient information to make informed choices. The CCM has the authority to recommend policy changes, propose regulatory interventions, or refer specific conduct to further legal proceedings if it finds competition is being harmed. **What this means for Mauritians** If the inquiry uncovers anti-competitive behaviour or structural problems, it could lead to new regulations on pricing transparency, limits on exclusive agreements between insurers and hospitals, or recommendations for government intervention. For patients, the long-term hope is more affordable and more fairly priced private care. The inquiry is expected to take several months, during which the CCM will consult with industry stakeholders, patient groups, and regulators including the Ministry of Health. Source: Le Defi Media